The Ability of Nicotinamide to Inhibit the Growth of a C3H Mouse Mammary Carcinoma

References

• Zackheim H S. Topical 6-aminonicotinamide plus oral niacinamide therapy for psoriasis. Arch Dermatol 1978; 114: 1632–8
   PubMed Web of Science ®Google Scholar
• Green R G. Subclinical pellagra: its diagnosis and treatment. Schizophrenia 1970; 2: 70–9
   Google Scholar
• Chouinard G, Young S N, Annable L, Sourkes T L. Trytophan-nicotinamide combination in depression. Lancet 1977; 1: 249
   PubMedGoogle Scholar
• Hawkins D R. Treatment of schizophrenia based on the medical model. J Schizophrenia 1968; 2: 3–10
   Google Scholar
• Elliott R B, Chase H P. Prevention or delay of type 1 (insulin-dependent) diabetes mellitus in children using nicotinamide. Diabetologia 1991; 34: 362–5
   PubMed Web of Science ®Google Scholar
• Neumann R, Rappold E, Pohl-Markl H. Treatment of polymorphous light eruption with nicotinamide: a pilot study. Br J Dermatol 1986; 115: 77–80
   PubMed Web of Science ®Google Scholar
• Haslam R HA, Dalby J T, Rademaker A W. Effects of megavitamin therapy on children with attention deficit disorders. Pediatrics 1984; 74: 103–11
   PubMed Web of Science ®Google Scholar
• Horsman M R, Hansen P V, Overgaard J. Radiosensitization by nicotinamide in tumors and normal tissues: the importance of tissue oxygenation status. Int J Radiat Oncol Biol Phys 1989; 16: 1273–6
   PubMed Web of Science ®Google Scholar
• Horsman M R, Chaplin D J, Overgaard J. Combination of nicotinamide and hyperthermia to eliminate radioresistant chronically and acutely hypoxic tumor cells. Cancer Res 1990; 50: 7430–6
   PubMed Web of Science ®Google Scholar
• Kjellen E, Joiner M C, Collier J M, Johns H, Rojas A. A therapeutic benefit from combining normobaric carbogen or oxygen with nicotinamide in fractionated x-ray treatments. Radiother Oncol 1991; 22: 81–91
   PubMed Web of Science ®Google Scholar
• Schoental R. The role of nicotinamide and of certain other modifying factors in diethylnitrosamine carcinogenesis. Cancer 1977; 40: 1833–40
   PubMed Web of Science ®Google Scholar
• Gotoh H, Nomura T, Nakajima H, Hasegawa C, Sakamoto Y. Inhibiting effects of nicotinamide on urethane-induced malformations and tumors in mice. Mutat Res 1988; 199: 55–63
   PubMed Web of Science ®Google Scholar
• Ludwig A, Dietel M, Schäfer G, Müller K, Hilz H. Nicotinamide and nicotinamide analogues as antitumor promoters in mouse skin. Cancer Res 1990; 50: 2470–5
   PubMed Web of Science ®Google Scholar
• Ross W CJ. Some 6-substituted nicotinamides: synthesis and antineoplastic activities. Biochem Pharmacol 1967; 16: 675–80
   PubMedGoogle Scholar
• Grassetti D R. The antimetastatic and tumor growth retarding effects of sulfur containing analogs of nicotinamide. Cancer Lett 1986; 31: 187–95
   PubMed Web of Science ®Google Scholar
• Gotoh H, Nomura T, Hasegawa C. Growth inhibition of transplanted murine breast cancer by nicotinamide in C3H/HeJ mice. Cancer Res Ther Cont. 1993; 3: 121–6
   Google Scholar
• Hiromatsu Y, Sato M, Yamada K, Nonaka K. Inhibitory effects of nicotinamide on recombinant human interferon-gamma-induced intercellular adhesion molecule-1 (ICAM-1) and HLA-DR antigen expression on cultured human endothelial cells. Immunol Lett 1991; 31: 35–40
   Google Scholar
• Folkman J. What is the evidence that tumours are angiogenesis dependent?. J Natl Cancer Inst 1990; 82: 4–6
   PubMed Web of Science ®Google Scholar
• Ingber D, Fujita T, Kishimoto S, et al. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature 1990; 348: 555–7
   PubMed Web of Science ®Google Scholar
• Overgaard J. Simultaneous and sequential hyperthermia and radiation treatment of an experimental tumor and its surrounding normal tissue in vivo. Int J Radiat Oncol Biol Phys 1980; 6: 1507–17
   PubMed Web of Science ®Google Scholar
• Kull F C, Brent D A, Parikh I, Cuatrecasas P. Chemical identification of a tumor-derived angiogenic factor. Science 1987; 236: 843–5
   PubMedGoogle Scholar
• Zackheim H S, Vasily D B, Westphal M L, Hastings C W. Reactions to niacinamide. J Am Acad Dermatol 1981; 4: 736–7
   PubMed Web of Science ®Google Scholar
• Horsman M R, Høyer M, Honess D J, Dennis I F, Overgaard J. Nicotinamide pharmacokinetics in humans and mice: a comparative assessment and the implications for radiotherapy. Radiother Oncol 1993; 27: 131–9
   PubMed Web of Science ®Google Scholar